Loading. Please wait.
We have seen this before, artificial neural networks, analytics, big data analytics, and now AI. These are not all the same terms, but the message has been the same over the past 10-20 years. The use of data and algorithms is going to transform medical devices and healthcare, more broadly. To some degree it has...
Top 3 reasons why your surgical robotics development program is late It is a reality of Medtech product development that programs often run longer than planned. These products are increasingly complex, and with product complexity comes program uncertainty. Underneath each Medtech program is an intricate mesh of parallel development tracks, gating inter-dependencies, technical risks, and verification...
On April 29, 2024, the FDA announced a final rule that amends the FDA regulations to bring laboratory developed tests (LDTs) under the Federal Food, Drug, and Cosmetic Act (FD&C Act). While much of the industry scrambles to understand the implications, manufacturers will find the new rule provides a significant opportunity for LDT device...
Full Spectrum hosted a webinar with MassMEDIC titles “The Ugly Truth about AI in Healthcare” on June 20th, 2024. Full Spectrum’s President & CCO Matt Eisendrath was joined by experts Rose Higgins, CEO of Dr. Evidence and Raid Afana, Sr. Director / Program Leader at Roche. The ugly truth about AI in healthcare is...
The healthcare ecosystem has been rapidly evolving over the past few decades, and it seems to be accelerating. Developing more cost-effective methods of addressing chronic diseases, such as cardiac-related illness, is a high priority. The fairly recent evolution of Patient Support Programs (PSP) is increasingly seen as having the potential to address this need. ...
Full Spectrum’s Matt Eisendrath, President and Chief Commercial Officer moderated a session at the LSI USA ’24 Emerging Medtech Summit on March 21, 2024. Matt’s introduction highlighted the challenges of getting regulated medical products and solutions to market citing the sobering statistic that “on average, software-based development programs will run two thirds over the...
Many organizations, eyeing their cloud adoption initiatives in the rearview mirror, are beginning to suffer some buyer’s remorse. Either the promise of the public cloud has failed to materialize, or perhaps sights were set on the wrong goals to begin with. A misapplication of the “lift-and-shift” cloud migration pattern is often the root cause of...
The integration of artificial intelligence (AI) in medical imaging has been a rapidly evolving and promising area of development. A quick look at this year’s RSNA program will attest to the overarching interest in AI, and for good reason. AI technologies, particularly machine learning algorithms, have shown great results within the medical diagnostic imaging industry,...
The rate of change in the field of oncology has continued to accelerate, with an information doubling expected to occur every two months – or expanding at the rate of 64x per year. The oncology field has long since crossed the line that individuals can keep pace with the rate of increasing knowledge. It shouldn’t...
Recently, the New York Times had an article on Page 1, above the fold, titled, “Suddenly, It Looks Like We’re in a Golden Age for Medicine”. As the piece describes, the explosion of the utility of new biotech technologies, from CRISPR to mRNA, is leading to a continuous stream of new molecules targeted at an...